-transparent.png){kind=logo}
Disodium mercaptoundecahydro-closo-dodecaborate (BSH) was studied for mutgenic potential by reverse mutation test with bacteria. The test was carried out using five different tester strains, S. typhimurium TA100, TA1535, TA98 and TA1537, and E. coli WP2uvrA by the preincubation method. BSH was tested at concentrations ranging from 156 to 5000 micrograms per plate. The test substance did not induce revertants dose-dependently in any strains with or without a metabolic activation system. Therefore, it was concluded that BSH was not mutagenic in the present reverse mutation test.
Related Publications
Y Miyake, and
Y Nishimoto
October 1998,
The Journal of toxicological sciences,
Y Miyake, and
Y Nishimoto
October 1998,
The Journal of toxicological sciences,
Y Miyake, and
Y Nishimoto
November 2003,
Acta neurochirurgica,
Y Miyake, and
Y Nishimoto
December 2011,
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine,
Y Miyake, and
Y Nishimoto
January 1987,
International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes,
Y Miyake, and
Y Nishimoto
April 2002,
Journal of neuro-oncology,
Y Miyake, and
Y Nishimoto
February 2006,
Angewandte Chemie (International ed. in English),
Y Miyake, and
Y Nishimoto
October 2016,
Inorganic chemistry,
Y Miyake, and
Y Nishimoto
March 2001,
Journal of the American Chemical Society,
